Go directly to content


Pre-conference workshop

EU-OPENSCREEN will host a workshop prior to the opening of BIOPROSP_23, on 14 March from 09.00 to 12.00. All participants at BIOPROSP_23 can attend the workshop, but there is a maximum capacity of 55 participants.

Please opt for "Pre-conference workshop" as an add-on in the registry form for the conference. The add-on appears after you have chosen one of the Event fees.

Workshop abstract:

Thanks to their molecular complexity and collective scaffold diversity, bioactive natural products represent a valuable source for drug discovery efforts. However, only a fraction of reported scaffolds are available in commercial libraries and access to HTS-amenable libraries remains an important challenge. During this pre-conference EU-OPENSCREEN workshop, we will discuss how publicly available repositories, local bioprospecting efforts and research infrastructures can help expand the availability of high quality, well annotated natural product-based libraries for screening. Our speakers will present publicly available resources in Europe, which are available to the research community; local efforts in bioprospecting and creating local collections; and collaborative initiatives to expose natural compounds to a broad range of biological targets in screening efforts.

Workshop Chairs:

  • Jeanette Andersen, University of Tromsø
  • Bahne Stechmann, EU-OPENSCREEN


  • Welcome and Introduction. Jeanette Andersen, University of Tromsø
  • EU-OPENSCREEN: A multinational initiative to support collaborative projects in chemical biology. Bahne Stechmann, EU-OPENSCREEN
  • Marine natural products bioprospecting and collaboration opportunities at EU-OPENSCREEN. Olga Genilloud, Fundación MEDINA
  • Marine natural products - challenges and opportunities for HTS discoveries. Päivi Tammela, University of Helsinki
  • Exploring the chemical and biological potential of marine organisms through metabolomics and chemical biology. Mark Brönstrup, HZI Braunschweig
  • Natural Products as Drug Candidates and Targeted Modulators of the Immune System. Angelo Fontana, ICB-CNR Naples
  • Expanding the chemical space of ribosomal peptide natural products. Jörn Piel, ETH
  • Improving clinical trial outputs – the need for comprehensive compound profiling of potential drug molecules. Sheraz Gul, Fraunhofer ITMP
  • Creation and screening of natural product libraries from an industrial point of view. Karsten Siems, AnalytiCon Discovery